Similar articles for PMID: 17000657

Year	Number of Results
2003	2
2004	2
2005	2
2006	13
2007	6
2008	7
2009	6
2010	6
2011	6
2012	4
2013	2
2014	5
2015	7
2016	1
2024	0

1

Studying human regulatory T cells in vivo.

Zorn E, Ritz J. Zorn E, et al. Clin Cancer Res. 2006 Sep 15;12(18):5265-7. doi: 10.1158/1078-0432.CCR-06-1417. Clin Cancer Res. 2006. PMID: 17000657 Review. No abstract available.

2

Regulatory T cells fulfil their promise?

Humblet-Baron S, Baron F, Liston A. Humblet-Baron S, et al. Immunol Cell Biol. 2011 Nov;89(8):825-6. doi: 10.1038/icb.2011.52. Epub 2011 May 24. Immunol Cell Biol. 2011. PMID: 21606944 Free article. No abstract available.

3

Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice.

Mutis T, van Rijn RS, Simonetti ER, Aarts-Riemens T, Emmelot ME, van Bloois L, Martens A, Verdonck LF, Ebeling SB. Mutis T, et al. Clin Cancer Res. 2006 Sep 15;12(18):5520-5. doi: 10.1158/1078-0432.CCR-06-0035. Clin Cancer Res. 2006. PMID: 17000688

4

Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.

Yang J, Fan H, Hao J, Ren Y, Chen L, Li G, Xie R, Yang Y, Qian K, Liu M. Yang J, et al. Transfusion. 2012 Jun;52(6):1333-47. doi: 10.1111/j.1537-2995.2011.03448.x. Epub 2011 Nov 21. Transfusion. 2012. PMID: 22098312

5

CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation.

Maury S, Lemoine FM, Hicheri Y, Rosenzwajg M, Badoual C, Cheraï M, Beaumont JL, Azar N, Dhedin N, Sirvent A, Buzyn A, Rubio MT, Vigouroux S, Montagne O, Bories D, Roudot-Thoraval F, Vernant JP, Cordonnier C, Klatzmann D, Cohen JL. Maury S, et al. Sci Transl Med. 2010 Jul 21;2(41):41ra52. doi: 10.1126/scitranslmed.3001302. Sci Transl Med. 2010. PMID: 20650872 Clinical Trial.

6

HLA-A2.1-restricted T cells react to SEREX-defined tumor antigen CML66L and are suppressed by CD4+CD25+ regulatory T cells.

Yan Y, Chen Y, Yang F, Chen IH, Xiong Z, Wang J, Lachman LB, Wang H, Yang XF. Yan Y, et al. Int J Immunopathol Pharmacol. 2007 Jan-Mar;20(1):75-89. doi: 10.1177/039463200702000109. Int J Immunopathol Pharmacol. 2007. PMID: 17346430 Free PMC article.

7

IFN-gamma promotes generation of IL-10 secreting CD4+ T cells that suppress generation of CD8 responses in an antigen-experienced host.

Liu XS, Leerberg J, MacDonald K, Leggatt GR, Frazer IH. Liu XS, et al. J Immunol. 2009 Jul 1;183(1):51-8. doi: 10.4049/jimmunol.0802047. Epub 2009 Jun 17. J Immunol. 2009. PMID: 19535638

8

[Influence of donor T(reg) cells on GVHD and hematopoietic reconstitution after allogeneic bone marrow transplantation in mice].

Yang K, Liu QF, Fan ZP, Zhang Y. Yang K, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Jun;15(3):547-52. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007. PMID: 17605863 Chinese.

9

Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.

Jones SC, Murphy GF, Korngold R. Jones SC, et al. Biol Blood Marrow Transplant. 2003 Apr;9(4):243-56. doi: 10.1053/bbmt.2003.50027. Biol Blood Marrow Transplant. 2003. PMID: 12720217 Free article.

10

The role of CD4+CD25hi regulatory T cells in the physiopathogeny of graft-versus-host disease.

Cohen JL, Boyer O. Cohen JL, et al. Curr Opin Immunol. 2006 Oct;18(5):580-5. doi: 10.1016/j.coi.2006.07.007. Epub 2006 Aug 1. Curr Opin Immunol. 2006. PMID: 16879951 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

63 results

Results by year